ras oncogene expression determines sensitivity for intercellular induction of apoptosis.

Area of Science:

• Cell Biology
• Oncology
• Molecular Biology

Background:

• Fibroblasts acquire a transformed phenotype upon induction of a ras oncogene.
• Transformed cells exhibit sensitivity to intercellular apoptosis induction by non-transformed cells.
• This process represents a novel regulatory mechanism against transformed cells.

Purpose of the Study:

• To elucidate the molecular mechanisms linking ras oncogene expression to apoptosis sensitivity.
• To investigate the role of reactive oxygen species and endogenous inhibitors in this process.
• To understand the interplay between ras activation, TGF-beta, and apoptosis induction.

Main Methods:

• Utilized fibroblasts with an inducible ras oncogene.
• Analyzed extracellular superoxide anion production and reactive oxygen species (ROS) generation.
• Assessed changes in endogenous apoptosis inhibitors and sensitivity to apoptosis-inducing agents.

Main Results:

• Ras oncogene expression leads to extracellular superoxide anion production, crucial for apoptosis induction.
• Superoxide anions facilitate HOCl and hydroxyl radical generation, directing apoptosis.
• Ras activation decreases short-lived endogenous apoptosis inhibitors, enhancing sensitivity to stimuli like cycloheximide and ceramide.
• TGF-beta reduces apoptosis inhibitors but does not induce transformation; combined with ras, it enhances apoptosis induction.

Conclusions:

• Ras-mediated superoxide anion production is the primary determinant of sensitivity to intercellular apoptosis induction.
• The reduction in endogenous apoptosis inhibitors modulates the speed and efficiency of apoptosis.
• This study reveals a complex interplay between oncogene activation, ROS signaling, and apoptosis regulation in cancer.